Hexagon Bio Raises a $47 Million Series A to Develop Fungi-Based Medicine
California-based Hexagon Bio has closed a $47 million Series A funding round led by The Column Group, with participation from 8VC and Two Sigma Ventures.
Source: greenqueen.com.hk